DENDRITIC AND T CELLS IN ANTI-BACTERIAL Ig RESPONSES

树突状细胞和 T 细胞在抗菌 Ig 反应中的作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): Infections due to extracellular bacteria continue to pose a significant global health problem. This is due in large part to the continual emergence of antibiotic-resistant strains. Hence, there exists an urgent need for development of protective vaccines. Immunity is mediated by antibodies to the bacterial polysaccharides (PS) as well as proteins. However, little is known regarding the parameters that mediate in vivo anti-PS and anti-protein responses to intact extracellular bacteria, although such information has relevance to the rational design of immunotherapies for these agents. We have established an in vivo model system for investigating the mechanism of induction of anti-PS and anti-protein Ig isotypes in response to intact Streptococcus pneumoniae. Specifically, the Ig isotype response to the phosphorylcholine (PC) determinant, present on the bacterial cell wall C-PS is studied and compared to the humoral response to a cell wall protein, pneumococcal surface protein A (PspA). We show that induction of optimal anti-PC and anti-PspA responses both require CD4+TCR-a/b+ T cells and B7-dependent costimulation, although memory fails to develop for induction of PC-specific Ig. Of interest, the mechanisms underlying the T cell-dependence of these two responses are distinct. We further show that dendritic cells (DCs) can phagocytose S. pneumoniae upon transfer into naive mice, induce both anti-PC and anti-PspA Ig responses, and the formation of PspA-specific memory. The general aims of this application are to elucidate the mechanisms by which DCs respond to and process an intact extracellular bacterium for induction of both T cell-dependent PC- and PspA-specific Ig isotypes in vivo, and determine the mechanisms underlying the distinct forms of T cell help that stimulate these respective antigen-specific Ig isotype responses. Specifically, we will utilize a number of in vitro and in vivo model systems to determine 1) the parameters that regulate DC activation and antigen presentation in response to R36A, 2) the relative contribution of DC subsets, and 3) the role of DC cytokines and accessory molecules, including CD40, MHC class 11, and Toll-like receptors. In this context, 4) the differential requirements for DC stimulation of T cell help for the anti-PC versus the anti-PspA response will be determined. These data will be the first to establish the detailed parameters that mediate a physiological antigen-specific humoral immune response to an intact extracellular bacterium, including the delineation of the fundamental differences between polysaccharide and protein-specific Ig isotype responses.
描述(由申请人提供):由细胞外细菌引起的感染

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CLIFFORD M SNAPPER其他文献

CLIFFORD M SNAPPER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CLIFFORD M SNAPPER', 18)}}的其他基金

(Poly)glycerolphosphate-based, cross-protective anti-staphylococcal vaccine
基于(聚)甘油磷酸盐的交叉保护性抗葡萄球菌疫苗
  • 批准号:
    8074028
  • 财政年份:
    2010
  • 资助金额:
    $ 25.94万
  • 项目类别:
(Poly)glycerolphosphate-based, cross-protective anti-staphylococcal vaccine
基于(聚)甘油磷酸盐的交叉保护性抗葡萄球菌疫苗
  • 批准号:
    7963436
  • 财政年份:
    2010
  • 资助金额:
    $ 25.94万
  • 项目类别:
GP350 AS A NOVEL VACCINE PROTEIN CARRIER
GP350 作为新型疫苗蛋白载体
  • 批准号:
    7958394
  • 财政年份:
    2009
  • 资助金额:
    $ 25.94万
  • 项目类别:
GP350 AS A NOVEL VACCINE PROTEIN CARRIER
GP350 作为新型疫苗蛋白载体
  • 批准号:
    7562069
  • 财政年份:
    2007
  • 资助金额:
    $ 25.94万
  • 项目类别:
Novel Carrier for Polysaccharide Conjugates and an EBV Vaccine
多糖缀合物和 EBV 疫苗的新型载体
  • 批准号:
    7537173
  • 财政年份:
    2007
  • 资助金额:
    $ 25.94万
  • 项目类别:
Novel Carrier for Polysaccharide Conjugates and an EBV Vaccine
多糖缀合物和 EBV 疫苗的新型载体
  • 批准号:
    7388052
  • 财政年份:
    2007
  • 资助金额:
    $ 25.94万
  • 项目类别:
GP350 AS A NOVEL VACCINE PROTEIN CARRIER
GP350 作为新型疫苗蛋白载体
  • 批准号:
    7349607
  • 财政年份:
    2006
  • 资助金额:
    $ 25.94万
  • 项目类别:
DENDRITIC AND T CELLS IN ANTI-BACTERIAL lg RESPONSES
树突状细胞和 T 细胞在抗细菌 lg 反应中的作用
  • 批准号:
    7219524
  • 财政年份:
    2001
  • 资助金额:
    $ 25.94万
  • 项目类别:
DENDRITIC AND T CELLS IN ANTI-BACTERIAL Ig RESPONSES
树突状细胞和 T 细胞在抗菌 Ig 反应中的作用
  • 批准号:
    6317430
  • 财政年份:
    2001
  • 资助金额:
    $ 25.94万
  • 项目类别:
DENDRITIC AND T CELLS IN ANTI-BACTERIAL lg RESPONSES
树突状细胞和 T 细胞在抗细菌 lg 反应中的作用
  • 批准号:
    7782763
  • 财政年份:
    2001
  • 资助金额:
    $ 25.94万
  • 项目类别:

相似海外基金

MHC Class II Antigen Presentation In Melanoma: Impact on Immune Recognition
黑色素瘤中 MHC II 类抗原的呈现:对免疫识别的影响
  • 批准号:
    10674177
  • 财政年份:
    2021
  • 资助金额:
    $ 25.94万
  • 项目类别:
MHC class II antigen presentation in melanoma: impact on immune recognition
黑色素瘤中 MHC II 类抗原呈递:对免疫识别的影响
  • 批准号:
    10618790
  • 财政年份:
    2021
  • 资助金额:
    $ 25.94万
  • 项目类别:
MHC class II antigen presentation in melanoma: impact on immune recognition
黑色素瘤中 MHC II 类抗原呈递:对免疫识别的影响
  • 批准号:
    10392325
  • 财政年份:
    2021
  • 资助金额:
    $ 25.94万
  • 项目类别:
VARIATION IN MHC CLASS II ANTIGEN BINDING SITE OF ATLANTIC SALMON, SALMO SALAR
大西洋鲑鱼 SALMO SALAR MHC II 类抗原结合位点的变异
  • 批准号:
    8360306
  • 财政年份:
    2011
  • 资助金额:
    $ 25.94万
  • 项目类别:
VARIATION IN MHC CLASS II ANTIGEN BINDING SITE OF ATLANTIC SALMON, SALMO SALAR
大西洋鲑鱼 SALMO SALAR MHC II 类抗原结合位点的变异
  • 批准号:
    8167705
  • 财政年份:
    2010
  • 资助金额:
    $ 25.94万
  • 项目类别:
MHC Class II Antigen Processing and Immune Recognition of Melanoma
MHC II 类抗原加工和黑色素瘤的免疫识别
  • 批准号:
    8131116
  • 财政年份:
    2007
  • 资助金额:
    $ 25.94万
  • 项目类别:
MHC Class II Antigen Processing and Immune Recognition of Melanoma
MHC II 类抗原加工和黑色素瘤的免疫识别
  • 批准号:
    7321929
  • 财政年份:
    2007
  • 资助金额:
    $ 25.94万
  • 项目类别:
MHC Class II Antigen Processing and Immune Recognition of Melanoma
MHC II 类抗原加工和黑色素瘤的免疫识别
  • 批准号:
    7673392
  • 财政年份:
    2007
  • 资助金额:
    $ 25.94万
  • 项目类别:
MHC Class II Antigen Processing and Immune Recognition of Melanoma
MHC II 类抗原加工和黑色素瘤的免疫识别
  • 批准号:
    7483748
  • 财政年份:
    2007
  • 资助金额:
    $ 25.94万
  • 项目类别:
MHC Class II Antigen Processing and Immune Recognition of Melanoma
MHC II 类抗原加工和黑色素瘤的免疫识别
  • 批准号:
    7907767
  • 财政年份:
    2007
  • 资助金额:
    $ 25.94万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了